Tel:
Fax:
Email:
Creative Biolabs

Parkinson's Disease Related Antibodies

The four most important motor symptoms of Parkinson's disease (PD), the second most prevalent chronic neurodegenerative disease, are tremor, bradykinesia, rigidity, and postural instability. As the disease progresses, non-motor symptoms like cognitive impairment, aberrant behavior, and sleep difficulties could appear. The loss of dopaminergic neurons in the substantia nigra pars compacta, a reduction in striatal dopamine, and the development of Lewy bodies—abnormal protein clumps within neurons—are pathological features of PD.

Key Factors Important Targets Related Products

Key Factors

After years of learning, scientists have made considerable progress toward understanding the pathophysiology of PD, however the disease's cause is still unknown. Monogenic PD is shown to be caused by mutations in several genes, and new loci linked to sporadic disease have been revealed using GWAS. Mutations in six genes (SNCA, LRRK2, PRKN, DJ1, PINK1, and ATP13A2) have been associated with PD. Loss-of-function mutations in GBA and polymorphisms in three genes—MAPT, LRRK2, and SNCA—are additional risk factors. In addition to genetics, protein aggregation and misfolding, oxidative stress, mitochondrial dysfunction, and neuroinflammation are all linked to the causes of PD. Environmental factors, such as mitochondrial toxicants, heavy metals that can cause oxidative stress and neurotransmission impairment, air pollution, or traumatic brain injury, are major risk factors for PD.

Fig 1 Parkinson's disease-related signaling pathways. (Dong-Chen, et al., 2023) Fig.1 Intracellular α-synuclein homeostasis is sustained by the lysosomal autophagy and ubiquitin–proteasome pathways1.

Important Targets Related to PD

Antibodies have excellent specificity and affinity, making them valuable tools for researchers exploring the pathophysiology of PD. Creative Biolabs provides a wide range of application-proven antibodies for researching proteins related to Parkinson's disease.

PARK7 PRKN ATP13A2 FBXO7 SLC6A3 SYNJ1 VPS35
Cat. No Product Name Host Application
NAB2010178LS NeuroMab™ Mouse Anti-Human PARK7 / DJ1 Monoclonal Antibody (CBP2257) Monoclonal WB; IHC-P
NPP2011ZP60 Human PARK7 Antibody Pair Monoclonal ELISA
NAB-0720-Z5694 Mouse Anti-PARK7 Monoclonal Antibody (CBP3109) Monoclonal FC; IHC-Fr; ICC; IF; WB; ICC; IHC-Fr
NAB-0720-Z5695 Rabbit Anti-PARK7 Monoclonal Antibody (CBP3110) Monoclonal WB; IHC-P; ICC; FC
NAB2105128SL NeuroMab™ Mouse Anti-Human PARK7 (CBP5652) Monoclonal ELISA; WB
NAB2007FY442 Human Anti-DJ-1 (CBP1952) Monoclonal ELISA; WB

See all PARK7 antibodies

Cat. No Product Name Host Application
NRZP-0822-ZP881 NeuroMab™ Anti-Parkin Antibody, Clone N10976P (CBP9238) Monoclonal WB; FC; ICC; IF; IHC; IHC-P; IP
NAB201284LS Mouse Anti-Human PARK2 Monoclonal Antibody (CBP3727) Monoclonal WB
NAB2010475LS Mouse Anti-Parkin Monoclonal Antibody (CBP2406) Monoclonal WB; ICC; IHC-P
NPP2011ZP50 Human Parkin Antibody Pair Kit ELISA

See all PRKN antibodies

Cat. No Product Name Host Application
NAB2105131SL NeuroMab™ Mouse Anti-Human ATP13A2 (CBP5654) Monoclonal ELISA; WB

See all ATP13A2 antibodies

Cat. No Product Name Host Application
NAB2010569LS NeuroMab™ Rat Anti-Human FBXO7 Monoclonal Antibody (CBP2465) Monoclonal WB; ICC
NAB2105133SL NeuroMab™ Mouse Anti-Human FBXO7 (CBP5655) Monoclonal ELISA; WB
NRZP-0922-ZP2441 NeuroMab™ Anti-FBXO7 Antibody, Clone N29738 (CBP13752) Monoclonal WB

See all FBXO7 antibodies

Cat. No Product Name Host Application
NAB-0720-Z2246 NeuroMab™ Rabbit Anti-SLC6A3 Monoclonal Antibody (CBP577) Monoclonal WB; IHC-P; IHC-Fr; IP
NAB-0720-Z2265 NeuroMab™ Mouse Anti-SLC6A3 Monoclonal Antibody (CBP592) Monoclonal WB; IHC-P
NAB-0720-Z2266 Rat Anti-SLC6A3 Monoclonal Antibody (CBP593) Monoclonal IHC-P
NRZP-1222-ZP785 NeuroMab™ Anti-Dopamine transporter Antibody, Clone 9D5 Monoclonal In Vitro
NRZP-0822-ZP686 NeuroMab™ Anti-SLC6A3/DAT1 Antibody, Clone N27103P (CBP9162) Monoclonal WB; ELISA; ICC; IF; IHC; IHC-P; IP

See all SLC6A3 antibodies

Cat. No Product Name Host Application
NAB-0720-Z2263 Mouse Anti-SYNJ1 Monoclonal Antibody (CBP590) Monoclonal ICC; IF; WB; IHC-Fr; IP
NAB2109P317 NeuroMab™ Mouse Anti-Rat SYNJ1 Monoclonal Antibody (CBP6957) Monoclonal WB; IHC

See all SYNJ1 antibodies

Cat. No Product Name Host Application
NAB2007FY752 NeuroMab™ Mouse Anti-VPS35 Monoclonal Antibody (CBP2095) Monoclonal WB; IF; IP
NAB2007FY753 Mouse Anti-VPS35 Monoclonal Antibody (CBP2096) Monoclonal WB; IF; IP
NAB2007FY754 NeuroMab™ Rabbit Anti-VPS35 Monoclonal Antibody (CBP2097) Monoclonal WB; IP
NAB2007FY755 Mouse Anti-VPS35 Monoclonal Antibody (CBP2098) Monoclonal WB; IF; IP
NAB2007FY756 NeuroMab™ Mouse Anti-VPS35 Monoclonal Antibody (CBP2099) Monoclonal WB; IF; IP

See all VPS35 antibodies

If you have a query about PD-related antibodies, please click on the related products below or contact us directly and we will get back to you within 24 hours.

Reference

  1. Dong-Chen, Xu, et al. "Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions." Signal transduction and targeted therapy 8.1 (2023): 73.
For Research Use Only. Not For Clinical Use.

Product
Hot Products
Fill out this form for a quote Inquiry Form Send Inquiry
webinar
Inquiry Basket
compare

Send inquiry